( PR4US.com | Press Release | 2018-09-20 19:53:59 )
The global anti-obesity Drugs Market is segmented in by product:-Peripherally acting anti-obesity agents, centrally acting anti-obesity drugs; by mode of action:-Fat Absorption Inhibition, Food Intake Suppression:- Noradrenergic Drugs, Serotoninergic Drugs, Adrenergic Drug, Others; Increase Thermogenesis; Segmentation by Type:- Prescription Drugs, Over the Counter Drugs; Segmentation by Distribution Channel:- Hospital Pharmacy, Retail Pharmacy and by regions. Anti-Obesity Drugs Market is anticipated to mask a significant CAGR during the forecast period i.e. 2015-2021.
Anti-obesity drugs are pharmacological agents that are used to lose cholesterol and reduce the body weight. These drugs generally show their action by altering the fundamental functioning of the normal body by utilization of calories or by altering the appetite. The World Health Organization reveals that global obesity has more than doubled since 1980, with over 1.9 billion adults overweight in 2014, of which, more than 600 million were obese.
North America’s anti-obesity drugs market is predicted to have a mushroomed growth through the forecast period i.e. 2015-2021. The market is probable to get driven due to expanding healthcare industry, increasing cases of obesity and various government initiatives to control and keep in check obesity problems. Asia-Pacific anti-obesity drugs market is estimated to strengthen supported by increase in disposable income and improvements in the healthcare sector.
Growing Concerns regarding Health
Escalating anxiety regarding health troubles associated to change in lifestyle, obesity, and existence of significant numbers of obese people worldwide are anticipated to aid the anti-obesity drugs market grow at a robust rate over the forecast period.
Request Report Sample@ https://bit.ly/2zPAhWf
However, some of the major challenges faces by global anti-obesity drugs market are side effects of anti-obesity drugs, cost constraints involved in R&D, and rising popularities of other alternatives (therapies, fitness spas, etc.) to reduce obesity.
The report titled “Global Anti-Obesity Drugs Market: Global Demand Analysis & Opportunity Outlook 2021” delivers detailed overview of the global anti-obesity drugs market in terms of market segmentation by product, by mode of action; by type; by distribution channel and by regions.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Request Free Table of Contents Here: https://bit.ly/2zQEKbh
This report also provides the existing competitive scenario of some of the key players of the global anti-obesity drugs market which includes company profiling of Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ag, GlaxoSmithKline plc, Takeda Pharmaceuticals Company Limited, Zafgen, Zydus Cadila, Rhythm Pharmaceuticals, Pfizer Inc., Merck & Co. Inc., Orexigen Therapeutics Inc., Boehringer Ingelheim Gmbh, Eisai Co. Ltd., Novo Nordisk A/S, Norgine B.V. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global anti-obesity drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Purchase this premium research report at: https://bit.ly/2Jy5cpu
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919